/Announcement on Resignation of Securities Affairs Representative
NEWS

Announcement on Resignation of Securities Affairs Representative

Shanghai Stock Exchange
2026/07/08

Securities code: 688373 Securities abbreviation: Mengke Pharmaceutical Announcement number: 2026-035

Shanghai Mengke Pharmaceutical Co., Ltd.

Announcement on the resignation of the securities affairs representative

The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents in accordance with the law.

The board of directors of Shanghai Mengke Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") recently received a resignation report submitted by Ms. Feng Zhu, the securities affairs representative. Due to personal reasons, Ms. Fengzhu applied to resign as the company's securities affairs representative. After her resignation, she will no longer hold any position in the company. Her resignation will be effective from the date it is delivered to the board of directors.

As of the disclosure date of this announcement, Ms. Fengzhu does not hold shares in the company, and there are no commitments that should be fulfilled but have not been fulfilled. The relevant work she is responsible for has been properly handed over, and her resignation will not affect the normal development of the company's relevant work. Ms. Fengzhu has been diligent, dedicated and conscientious during her tenure. The company and the board of directors express their sincere gratitude to Ms. Fengzhu for her contribution to the development of the company during her tenure.

In accordance with the "Shanghai Stock Exchange Science and Technology Innovation Board Stock Listing Rules", "Shanghai Stock Exchange Science and Technology Innovation Board Listed Companies Self-Regulatory Guidelines No. 1 - Standardized Operations" and other relevant regulations, the company will hire qualified personnel as the company's securities affairs representative as soon as possible to assist the company's board secretary in carrying out relevant work. Announcement is hereby made.

Board of Directors of Shanghai Mengke Pharmaceutical Co., Ltd.

July 8, 2026